Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4746.TW Stock Summary
Top 10 Correlated ETFs
4746.TW
In the News
4746.TW Financial details
Company Rating
Buy
Market Cap
12.09B
Income
82.83M
Revenue
4.36B
Book val./share
62.96
Cash/share
20.88
Dividend
1
Dividend %
0.98%
Employees
867
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
54.59
Forward P/E
12.41
PEG
-8.85
P/S
3.04
P/B
1.68
P/C
5.15
P/FCF
56.32
Quick Ratio
1.09
Current Ratio
1.63
Debt / Equity
0.53
LT Debt / Equity
0.25
-
-
EPS (TTM)
0.69
EPS next Y
8.66
EPS next Q
1.77
EPS this Y
-41.67%
EPS next Y
1155.07%
EPS next 5Y
1155.07%
EPS last 5Y
NAN%
Revenue last 5Y
9.58%
Revenue Q/Q
7.36%
EPS Q/Q
-260%
-
-
-
-
SMA20
-4.59%
SMA50
1.96%
SMA100
23.81%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
3%
ROC
0.03%
Gross Margin
44%
Oper. Margin
7%
Profit Margin
5%
Payout
-
Shs Outstand
120.26M
Shs Float
84.05M
-
-
-
-
Target Price
-
52W Range
67.6-121.0
52W High
-11.16%
52W Low
+60.45%
RSI
57
Rel Volume
0.63
Avg Volume
3.74M
Volume
2.35M
Perf Week
8.26%
Perf Month
-0.92%
Perf Quarter
23.99%
Perf Half Y
25.29%
-
-
-
-
Beta
0.801
-
-
Volatility
4.23%, 4.53%
Prev Close
-1.38%
Price
107.5
Change
-2.71%
4746.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 27.87 | 26.59 | 25.96 | 31.31 | 36.26 | |
Net income per share | -0.41 | 3.46 | 10.32 | 1.8 | 1.05 | |
Operating cash flow per share | 2.93 | 4.11 | 2.57 | 5.35 | 6.87 | |
Free cash flow per share | -11.43 | -4.64 | -1.67 | 1.69 | 2.37 | |
Cash per share | 4.85 | 7.02 | 9.03 | 13.56 | 20.88 | |
Book value per share | 44.05 | 45 | 61.09 | 62.54 | 62.96 | |
Tangible book value per share | 42.22 | 43.38 | 60.75 | 62.98 | 66.57 | |
Share holders equity per share | 44.05 | 45 | 61.09 | 62.54 | 62.96 | |
Interest debt per share | 37.16 | 27.6 | 28.5 | 31.77 | 34.28 | |
Market cap | 4.14B | 5.43B | 7.32B | 8.84B | 12.27B | |
Enterprise value | 7.34B | 8.01B | 10.02B | 11.36B | 14.8B | |
P/E ratio | -100.91 | 13.57 | 5.86 | 40.77 | 97.16 | |
Price to sales ratio | 1.5 | 1.77 | 2.33 | 2.35 | 2.81 | |
POCF ratio | 14.29 | 11.43 | 23.54 | 13.74 | 14.86 | |
PFCF ratio | -3.66 | -10.13 | -36.14 | 43.52 | 43.01 | |
P/B Ratio | 0.95 | 1.04 | 0.99 | 1.18 | 1.62 | |
PTB ratio | 0.95 | 1.04 | 0.99 | 1.18 | 1.62 | |
EV to sales | 2.66 | 2.61 | 3.19 | 3.02 | 3.4 | |
Enterprise value over EBITDA | 19.21 | 9.21 | 6.35 | 13.34 | 12.73 | |
EV to operating cash flow | 25.32 | 16.87 | 32.19 | 17.67 | 17.93 | |
EV to free cash flow | -6.49 | -14.94 | -49.43 | 55.93 | 51.91 | |
Earnings yield | -0.01 | 0.07 | 0.17 | 0.02 | 0.01 | |
Free cash flow yield | -0.27 | -0.1 | -0.03 | 0.02 | 0.02 | |
Debt to equity | 0.84 | 0.61 | 0.46 | 0.51 | 0.53 | |
Debt to assets | 0.38 | 0.31 | 0.28 | 0.3 | 0.3 | |
Net debt to EBITDA | 8.37 | 2.97 | 1.71 | 2.96 | 2.18 | |
Current ratio | 1.11 | 1.04 | 1.52 | 1.32 | 1.62 | |
Interest coverage | -0.08 | 14.74 | 39.28 | 19.71 | 8.68 | |
Income quality | -7.21 | 1.32 | 0.29 | 1.93 | 6.54 | |
Dividend Yield | 0.01 | 0 | 0 | 0.03 | 0.01 | |
Payout ratio | -1.21 | 0 | 0 | 1.11 | 0.95 | |
Sales general and administrative to revenue | 0.07 | 0.07 | 0.09 | 0.06 | 0.06 | |
Research and developement to revenue | 0.16 | 0.18 | 0.22 | 0.21 | 0.19 | |
Intangibles to total assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | |
Capex to operating cash flow | -4.9 | -2.13 | -1.65 | -0.68 | -0.65 | |
Capex to revenue | -0.52 | -0.33 | -0.16 | -0.12 | -0.12 | |
Capex to depreciation | -3.7 | -2.25 | -1.08 | -0.93 | -1.11 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 20.27 | 59.18 | 119.08 | 50.37 | 38.56 | |
ROIC | 0 | 0.05 | 0.1 | 0.02 | -0.02 | |
Return on tangible assets | 0 | 0.04 | 0.11 | 0.02 | 0.01 | |
Graham Net | -33.18 | -24.24 | -15.19 | -15.26 | -11.21 | |
Working capital | 275.27M | 108.26M | 1.23B | 1.01B | 2B | |
Tangible asset value | 4.13B | 5.02B | 7.35B | 7.57B | 8.01B | |
Net current asset value | -2.4B | -1.85B | -795.31M | -803.38M | -182.32M | |
Invested capital | 0.84 | 0.61 | 0.46 | 0.51 | 0.53 | |
Average receivables | 1.04B | 947.61M | 880.61M | 899.81M | 970.53M | |
Average payables | 198.07M | 187.06M | 205.28M | 194.45M | 194.29M | |
Average inventory | 1.27B | 1.35B | 1.55B | 1.62B | 1.6B | |
Days sales outstanding | 134.51 | 104.23 | 102.56 | 88.85 | 85.75 | |
Days payables outstanding | 31.32 | 35.66 | 34.03 | 28.65 | 30.02 | |
Days of inventory on hand | 235.34 | 248.62 | 275.6 | 246.12 | 237.3 | |
Receivables turnover | 2.71 | 3.5 | 3.56 | 4.11 | 4.26 | |
Payables turnover | 11.65 | 10.23 | 10.73 | 12.74 | 12.16 | |
Inventory turnover | 1.55 | 1.47 | 1.32 | 1.48 | 1.54 | |
ROE | -0.01 | 0.08 | 0.17 | 0.03 | 0.02 | |
Capex per share | -14.35 | -8.74 | -4.24 | -3.66 | -4.49 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.88 | 7.78 | 9.04 | 9.39 | 10.08 | |
Net income per share | 2.71 | -0.57 | 0.69 | -0.95 | 1.52 | |
Operating cash flow per share | 2.28 | 0.81 | -0.61 | 3.53 | 3.14 | |
Free cash flow per share | 1.35 | 0.05 | -1.77 | 2.27 | 1.83 | |
Cash per share | 13.56 | 12.81 | 17.66 | 18.5 | 20.88 | |
Book value per share | 62.54 | 62.56 | 62.32 | 61.34 | 62.96 | |
Tangible book value per share | 62.98 | 62.68 | 66.8 | 65.4 | 66.57 | |
Share holders equity per share | 62.54 | 62.56 | 62.32 | 61.34 | 62.96 | |
Interest debt per share | 31.66 | 31.08 | 32.83 | 32.77 | 33.83 | |
Market cap | 8.84B | 9.19B | 11.11B | 10.65B | 12.27B | |
Enterprise value | 11.36B | 11.55B | 13.11B | 13.35B | 14.8B | |
P/E ratio | 6.77 | -33.5 | 33.32 | -23.25 | 16.8 | |
Price to sales ratio | 8.27 | 9.86 | 10.22 | 9.44 | 10.12 | |
POCF ratio | 32.27 | 94.5 | -152.07 | 25.08 | 32.48 | |
PFCF ratio | 54.63 | 1.57K | -52.25 | 39.06 | 55.69 | |
P/B Ratio | 1.18 | 1.23 | 1.48 | 1.44 | 1.62 | |
PTB ratio | 1.18 | 1.23 | 1.48 | 1.44 | 1.62 | |
EV to sales | 10.63 | 12.39 | 12.06 | 11.82 | 12.21 | |
Enterprise value over EBITDA | 24.5 | 152.55 | 60.7 | 372 | 40.75 | |
EV to operating cash flow | 41.48 | 118.77 | -179.42 | 31.42 | 39.21 | |
EV to free cash flow | 70.22 | 1.98K | -61.65 | 48.95 | 67.22 | |
Earnings yield | 0.04 | -0.01 | 0.01 | -0.01 | 0.01 | |
Free cash flow yield | 0.02 | 0 | -0.02 | 0.03 | 0.02 | |
Debt to equity | 0.51 | 0.5 | 0.53 | 0.53 | 0.53 | |
Debt to assets | 0.3 | 0.3 | 0.29 | 0.3 | 0.3 | |
Net debt to EBITDA | 5.44 | 31.17 | 9.25 | 75.12 | 6.99 | |
Current ratio | 1.32 | 1.42 | 1.61 | 1.63 | 1.62 | |
Interest coverage | 54.81 | -4.23 | 57.71 | -10.25 | 10.26 | |
Income quality | 0.87 | -3.8 | -0.73 | -4.26 | 2.07 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
Payout ratio | 0 | 0 | 0 | -1.05 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.05 | 0.08 | 0.06 | 0.03 | |
Research and developement to revenue | 0.18 | 0.23 | 0.19 | 0.2 | 0.16 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Capex to operating cash flow | -0.41 | -0.94 | 1.91 | -0.36 | -0.42 | |
Capex to revenue | -0.1 | -0.1 | -0.13 | -0.13 | -0.13 | |
Capex to depreciation | -0.95 | -0.77 | -1.19 | -1.22 | -1.23 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 61.78 | 28.38 | 31.18 | 36.26 | 46.38 | |
ROIC | 0.03 | -0.01 | 0.01 | -0.01 | 0.01 | |
Return on tangible assets | 0.03 | -0.01 | 0.01 | -0.01 | 0.01 | |
Graham Net | -15.26 | -14.97 | -11.64 | -10.97 | -11.21 | |
Working capital | 1.01B | 1.21B | 1.92B | 1.95B | 2B | |
Tangible asset value | 7.57B | 7.51B | 8.03B | 7.87B | 8.01B | |
Net current asset value | -803.38M | -755.52M | -217.63M | -189.64M | -182.32M | |
Invested capital | 0.51 | 0.5 | 0.53 | 0.53 | 0.53 | |
Average receivables | 977.03M | 913.63M | 1.07B | 1.19B | 1.08B | |
Average payables | 174.74M | 170.53M | 179.41M | 198.61M | 197.56M | |
Average inventory | 1.58B | 1.61B | 1.67B | 1.7B | 1.63B | |
Days sales outstanding | 77.22 | 87.94 | 101.77 | 91.11 | 76.05 | |
Days payables outstanding | 27.01 | 26.75 | 31.24 | 27.05 | 26.31 | |
Days of inventory on hand | 231.96 | 278.62 | 265.44 | 232.52 | 207.98 | |
Receivables turnover | 1.17 | 1.02 | 0.88 | 0.99 | 1.18 | |
Payables turnover | 3.33 | 3.36 | 2.88 | 3.33 | 3.42 | |
Inventory turnover | 0.39 | 0.32 | 0.34 | 0.39 | 0.43 | |
ROE | 0.04 | -0.01 | 0.01 | -0.02 | 0.02 | |
Capex per share | -0.93 | -0.76 | -1.16 | -1.27 | -1.31 |
4746.TW Frequently Asked Questions
What is Formosa Laboratories, Inc. stock symbol ?
Formosa Laboratories, Inc. is a TW stock and trading under the symbol 4746.TW
What is Formosa Laboratories, Inc. stock quote today ?
Formosa Laboratories, Inc. stock price is $107.5 today.
Is Formosa Laboratories, Inc. stock public?
Yes, Formosa Laboratories, Inc. is a publicly traded company.